Vivek Ramaswamy
CIK 1635075 · Principal Executive Officer · last filed 2025-12-15
Vivek Ramaswamy is a Principal Executive Officer who has filed 32 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for ROIV, was dated Dec 15, 2025. Across all open-market trades the lifetime net is −$223.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.87B across reported positions. 36 SEC filings were submitted jointly with Roivant Sciences Ltd. 11 Form 144 notices of planned sales are also on file; the latest, for ROIV on Jun 20, 2025, lists the filer as a 10% owner. 3 sales listed on those notices, worth $3.1M in all, have no matching Form 4.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ROIV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
853 NEW JERSEY AVE., SE STE. 200-231
WASHINGTON, DC 20003
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | 10%+ Owner | 47,011,612 | $39.17 | $1.84B | -$193.16M | 10 | 2025-12-15 |
| ASST | 10%+ Owner | 1,419,722 | $16.80 | $23.84M | $1.25M | 2 | 2025-11-07 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 54,730,523 | $2.75 | $150.51M | -$31.80M | 4 | 2023-08-29 |
| ABUS | Director | — | $4.08 | — | $0 | 4 | 2018-06-22 |
Holdings By Holder
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-15 | ROIV | Mixed | −1 | -$67.92M | EDGAR |
| 2025-11-17 | ROIV | Sell (S) | −1,854,603 | -$37.94M | EDGAR |
| 2025-11-07 | ASST | Buy (P) | +15,625 | $1.25M | EDGAR |
| 2025-09-16 | ASST | — | — | $0 | EDGAR |
| 2025-09-05 | ROIV | Sell (S) | −1,775,749 | -$22.46M | EDGAR |
| 2025-06-23 | ROIV | Sell (S) | −1,142,273 | -$13.08M | EDGAR |
| 2025-06-20 | ROIV | Notice (144) 10% Owner · Planned Jun 20, 2025 Sold: Form 4 filed Jun 23, 2025 |
−577,007 | -$6.61M | EDGAR |
| 2025-06-18 | ROIV | Notice (144) 10% Owner · Planned Jun 18, 2025 Sold: Form 4 filed Jun 23, 2025 |
−565,266 | -$6.47M | EDGAR |
| 2025-06-06 | ROIV | Sell (S) | −748,230 | -$8.45M | EDGAR |
| 2025-06-06 | ROIV | Notice (144) 10% Owner · Planned Jun 6, 2025 Sold: Form 4 filed Jun 6, 2025 |
−200,800 | -$2.25M | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
3 sales · $3.13M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2023-08-28 | ROIV | 47,692 | $536.5K | $11.25 | 2023-09-28 |
| 2023-07-31 | ROIV | 76,023 | $868.9K | $11.43 | 2023-08-28 |
| 2023-05-31 | ROIV | 189,947 | $1.73M | $9.09 | 2023-07-28 |